/
/
/

Biocon Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)391.55
Volume (₹)36.66 L
High (₹)396.85
Upper Circuit403.65
Low (₹)384.65
Lower Circuit380.15
Prev Close391.65
52W High (₹)447.15
Price390.65
52W Low (₹)337.05

Share Market Cap & Key Ratios Overview

M.Cap (₹)64372.90 Cr
Div. Yield (%)0.13
PE Ratio129.97
Debt to Equity0.44
Price to Book1.75
Book Value206.77
EPS (TTM)3.04
Face Value5.00
ROE (%)1.35

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
AUROPHARMANSE
DRREDDYNSE
LUPINNSE
MANKINDNSE
BIOCONNSE
LTP
1W Low
1W High
Market cap (₹)
1840-24.9 (-1.34%)
1834
1907.80
4,47,236Cr
9322-166 (-1.75%)
9119.50
9615
2,49,673Cr
4965.5+35.5 (0.72%)
4823
5000
1,87,460Cr
1119.1-8.3 (-0.74%)
1104.60
1167.70
1,11,521Cr
1366+2.9 (0.21%)
1347.70
1398.40
1,11,484Cr
1969+32 (1.65%)
1832.70
1981.80
1,04,604Cr
1679.8-19.1 (-1.12%)
1646
1704
96,031Cr
1165.5+20.5 (1.79%)
1130
1182
95,220Cr
2095-5 (-0.24%)
2058
2135.50
94,883Cr
2280+15 (0.66%)
2222
2331.60
92,770Cr
390.65-4.35 (-1.10%)
384.65
403.95
63,558Cr

Key Highlights of Biocon Ltd Balance Sheet

Biocon Ltd balance sheet discloses shareholders' funds of ₹810.5Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹810.5Cr, and the reserves and surplus of the company is ₹26157Cr.

The company has its non-current liabilities with total liabilities of ₹29270.6Cr as of 2026-03-31.

The current liabilities are ₹1965.4Cr as of 2026-03-31. At the same time, current assets are ₹2288Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹24805.6Cr and tangible assets of ₹1331.1Cr, provided in the Biocon Ltd financial statements.